Board Member
Pulse Biosciences, Inc. (PLSE)Equibles does not estimate personal net worth.
Get an email with a short summary when Pulse Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get PLSE alertsPaul LaViolette is recorded as Board Member at Pulse Biosciences, Inc. (PLSE) since January 1, 2024 and CEO at Pulse Biosciences, Inc. (PLSE). The proxy statement of Pulse Biosciences, Inc. reports total compensation of $7,427,899 for Paul LaViolette in fiscal 2025, including a base salary of $708,523. Disclosed compensation is on record for 4 fiscal years. Paul LaViolette has spoken on 6 earnings calls and 6 other investor events across 1 company, most recently for Pulse Biosciences, Inc. on August 11, 2026. Pulse Biosciences, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Pulse Biosciences, Inc. includes Burke T. Barrett (CEO and Board Member), Kevin Danahy (CEO), Paul A. LaViolette (CEO, Chairman and Board Member) and 7 others.
“I was a summer intern for Kendall, which became part of Medtronic. And they hired me before I even went back to my second year of business school. So I was 23 and working in marketing and medtech.”
“Thank you, Tripp, and good afternoon and thank you everyone for joining us today to discuss the results of our very active second quarter of 2026.”
“I think it compares really favorably, to use your phrase, to the bevy of opportunities. If I think about what attracted me, it's not surprising, right, with what's going on in the field of PFA in the last couple of years that PFA, by definition, draws interest.”
“Thank you very much, and great to be joined by John and everyone interested in the Pulse Biosciences story. I'll be making forward-looking statements today, and this is our disclosure.”
“For those of you that are new to the Pulse Biosciences story, let me start with a brief overview of the technology at the core of everything we do.”
2024-01-01–present
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pulse Biosciences, Inc. (PLSE) | CEO | $708,523 | $7,427,899 |
| 2024 | Pulse Biosciences, Inc. (PLSE) | CEO | — | — |
| 2023 | Pulse Biosciences, Inc. (PLSE) | CEO | — | — |
| 2022 | Pulse Biosciences, Inc. (PLSE) | CEO | — | — |
